Evidence map›Paper›PMID 41726626›Full record

ArticleACS omega2026

Franciele Garcia Baveloni, Marco Antônio Utrera Martines, Bruna Almeida Furquim de Camargo, Marcela Tavares Luiz, Melina Borges Teixeira Zanatta, Isabella Carvalho Pereira da Silva, Hernane da Silva Barud, Guillermo R Castro, Amauri Antônio Menegário, Taís Maria Bauab and 2 more

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Franciele Garcia BaveloniDepartment of Drugs and Medicines, São Paulo State University (UNESP), Araraquara, São Paulo 14800-901, Brazil.ORCID https://orcid.org/0000-0002-9021-5245
Marco Antônio Utrera MartinesInstitute of Chemistry, Federal University of Mato Grosso Do Sul (UFMS), Campo Grande, Mato Grosso Do Sul 79074-460, Brazil.
Bruna Almeida Furquim de CamargoDepartment of Drugs and Medicines, São Paulo State University (UNESP), Araraquara, São Paulo 14800-901, Brazil.ORCID https://orcid.org/0000-0002-8442-0840
Marcela Tavares LuizDepartment of Drugs and Medicines, São Paulo State University (UNESP), Araraquara, São Paulo 14800-901, Brazil.
Melina Borges Teixeira ZanattaCenter for Environmental Studies, São Paulo State University (UNESP), Rio Claro, São Paulo 13506-900, Brazil.ORCID https://orcid.org/0000-0002-7132-1851
Isabella Carvalho Pereira da SilvaCenter for Environmental Studies, São Paulo State University (UNESP), Rio Claro, São Paulo 13506-900, Brazil.
Hernane da Silva BarudLaboratory of Biopolymers and Biomaterials, University of Araraquara (UNIARA), Araraquara, São Paulo 14801-320, Brazil.
Guillermo R CastroNanomedicine Research Unit, Center for Natural and Human Sciences, Federal University of ABC (UFABC), Santo André, São Paulo 09210-580, Brazil.
Amauri Antônio MenegárioCenter for Environmental Studies, São Paulo State University (UNESP), Rio Claro, São Paulo 13506-900, Brazil.
Taís Maria BauabDepartment of Drugs and Medicines, São Paulo State University (UNESP), Araraquara, São Paulo 14800-901, Brazil.
Andréia Bagliotti MeneguinDepartment of Drugs and Medicines, São Paulo State University (UNESP), Araraquara, São Paulo 14800-901, Brazil.
Marlus ChorilliDepartment of Drugs and Medicines, São Paulo State University (UNESP), Araraquara, São Paulo 14800-901, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complex wounds, burns, and diabetic complications increase patients' susceptibility to bacterial infections, which frequently show resistance to standard treatments. This investigation focused on evaluating the antimicrobial potential of lyotropic liquid crystal (LC) formulations loaded with silver nanoparticles (AgNPs) against

Identifiers

PMID41726626
PMCPMC12917788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.